Get started
Author

Elizabeth M. Salvo‐Halloran

Observed names: E. M. Salvo, E. Salvo, E.M. Salvo, Elizabeth M Salvo-Halloran, Elizabeth M. Salvo, Elizabeth M. Salvo-Halloran, Elizabeth Salvo-Halloran, Salvo-Halloran, Elizabeth, Salvo-Halloran, Elizabeth M.
Institution: EVERSANA (Canada)
ORCID: 0000-0002-1850-9855
Observed ORCID: 0000-0002-1850-9855
OpenAlex ID: A5022103583
Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors
2021 · Elizabeth M. Salvo, Nicole C. Ferko, et al. · Alimentary Pharmacology & Therapeutics · 78
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
2021 · Elizabeth M. Salvo, Abril Oliva Ramirez, et al. · The Breast · 76
An umbrella review of the surgical performance of Harmonic ultrasonic devices and impact on patient outcomes
2023 · Robert Kloosterman, George W. J. Wright, et al. · BMC Surgery · 17
PDF
Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema
2025 · Sarah Walsh, Meaghan Bartlett, et al. · Drugs in R&D · 15
PDF
Quantitative Point-of-Care Colorimetric Assay Modeling Using a Handheld Colorimeter
2021 · Kristen Abels, Elizabeth M. Salvo-Halloran, et al. · ACS Omega · 15
Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies
2024 · Robert Zivadinov, Alexander J. Keenan, et al. · BMC Neurology · 9
PDF
The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy
2020 · Imtiaz A. Samjoo, Elizabeth M. Salvo, et al. · Current Medical Research and Opinion · 6
PDF
Letter to the editor concerning the article: “An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy”
2019 · E. M. Salvo, I. A. Samjoo, et al. · Expert Opinion on Pharmacotherapy · 2
PDF
90P Patient-reported outcomes among patients with HR+/HER2- early breast cancer: A systematic literature review
2020 · E.M. Salvo, J. Cueto, et al. · Annals of Oncology · 1
A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2− Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence
2026 · Timothy Pluard, Thomas Grinda, et al. · Cancers
Msr80 Accelerating Evidence Generation: Leveraging Llms for Full-text Study Selection
2026 · Christopher Olsen, Jayson Brian Habib, et al. · Value in Health
Msr204 Accounting for Differences in Maintenance Study Designs: Methodological Considerations for Nma
2026 · Becky Hooper, Elizabeth Salvo-Halloran, et al. · Value in Health
Msr34 Assessment of Autonomous Literature Review Systems for Umbrella Review Screening
2026 · Kevin Kallmes, Vicki Young, et al. · Value in Health
Matching-adjusted indirect comparison of acoltremon ophthalmic solution 0.003% and cyclosporine 0.05% ophthalmic emulsion for increased tear production in patients with dry eye disease
2026 · Stephen Pflugfelder, Tony Okoro, et al. · Journal of Comparative Effectiveness Research
Supplementary data: Matching-adjusted indirect comparison of acoltremon ophthalmic solution 0.003% and cyclosporine 0.05% ophthalmic emulsion for increased tear production in patients with dry eye disease
2026 · Pflugfelder, Stephen, Okoro, Tony, et al. · Figshare
Letter: mind the gap—search and publication date of systematic reviews and meta‐analysis. Authors' reply
2021 · Elizabeth M. Salvo‐Halloran, Nicole C. Ferko, et al. · Alimentary Pharmacology & Therapeutics
PCN124 Health Utilities for Patients with HR-Positive, HER2-Negative EARLY Breast Cancer: A Systematic Literature Review
2020 · C. Aniceto da Silva, J. Cueto, et al. · Value in Health
PCN43 Risk of Recurrence Among Patients with HR-Positive, HER2-Negative, EARLY Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review and Meta-Analysis
2020 · A. Oliva Ramirez, E.H. Law, et al. · Value in Health
Pcn63 a Systematic Literature Review of the Economic Burden Among Patients With Hormone Receptor-positive, Her2-negative Early Breast Cancer
2020 · E. Salvo, S. Fogarty, et al. · Value in Health
PDF
Pns159 the Utility of Umbrella Reviews: a Case-study on the Safety of Proton Pump Inhibitors
2020 · E. Salvo, N. Ferko, et al. · Value in Health
Works count: 22
Citation count: 219
H-index: 6
I10-index: 5
Year
Topic
Type